Loading…
Based on limited metadata, this FDA Warning Letter issued to Shuzy Rock Inc. on September 1, 2022, concerns drug manufacturing or distribution operations. Without access to the full letter text or detailed subject information, the specific violations cannot be determined from the available metadata. The warning falls under FDA's drug regulatory authority, though the specific issuing office and violation count are not available in this record. Additional documentation would be needed to identify the particular compliance issues cited.